The heterogeneity in study designs, probiotic strains used, dosages, treatment durations, and participant populations makes it difficult to draw firm conclusions
The Ultimate Follicle Revitalization Treatment
Tirzepatide's appetite-suppressing power comes from slowing gastric emptying and increasing satiety hormones like GLP-1 and GIP
The broader TRIUMPH clinical trial program has enrolled more than 5,800 participants across studies examining retatrutide for obesity, overweight, obstructive sleep apnea, knee osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
A licensed clinician reviews your profile and, if appropriate, prescribes a personalized protocol
Tirzepatide works similarly to semaglutide but targets both GLP-1 and GIP receptors, which can lead to even greater average weight loss in studies (up to 20-21%) when combined with lifestyle changes